Other languages Synmosa Biopharma Corporation

Equities

4114

TW0004114004

End-of-day quote Taipei Exchange Other stock markets 03:30:00 13/05/2024 am IST			5-day change	1st Jan Change
39.55 ^TWD	0.00%		+1.15%	+2.33%

29/03	Synmosa Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
16/01	Synmosa Biopharma Corporation Announces Changes in Fifth Session of the Remuneration Committee	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Synmosa Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
Synmosa Biopharma Corporation Announces Changes in Fifth Session of the Remuneration Committee	16/01
Synmosa Biopharma Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Synmosa Biopharma Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/23/11
Synmosa Biopharma Corporation Announces Cash Dividend, Payable on September 15, 2023	24/23/24
Synmosa Biopharma Corporation Appoints Tu, San-Chien as Additional Independent Director	13/23/13
Synmosa Biopharma Corporation Appoints Tu, San-Chien as Member of the Audit Committee	13/23/13
Synmosa Biopharma Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15
Synmosa Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	31/23/31
Synmosa Biopharma Corporation Approves Dividend for the Year Ended December 31, 2022	13/23/13
Synmosa Biopharma Corporation Announces Changes of Corporate Governance Officer	18/23/18
Synmosa Biopharma Corporation Provides Earnings Guidance for the Year 2022	28/22/28
Synmosa Biopharma Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	12/22/12
Synmosa Biopharma Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12/22/12
Synmosa Biopharma Corporation Announces Changes to the Compensation Committee	22/22/22
Synmosa Biopharma Corporation Announces Cash Dividends, Payable on August 15, 2022	22/22/22
Synmosa Biopharma Corporation Announces Wang Chien-Jen as Independent Director	25/22/25
Synmosa Biopharma Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	13/22/13
Synmosa Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	30/22/30
Synmosa Biopharma Corporation announces an Equity Buyback for 4,000,000 shares, for TWD 1,177.47 million.	29/22/29

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Synmosa Biopharma Corporation

Equities

4114

TW0004114004

Other languages

Filters